{"id":"https://openalex.org/W4367363087","doi":"https://doi.org/10.1111/j.1742-1241.2003.tb10467.x","title":"GALANTAMINE: A REVIEW OF ITS USE IN ALZHEIMER'S DISEASE AND VASCULAR DEMENTIA","display_name":"GALANTAMINE: A REVIEW OF ITS USE IN ALZHEIMER'S DISEASE AND VASCULAR DEMENTIA","publication_year":2003,"publication_date":"2003-04-01","ids":{"openalex":"https://openalex.org/W4367363087","doi":"https://doi.org/10.1111/j.1742-1241.2003.tb10467.x","mag":"2300314858","pmid":"https://pubmed.ncbi.nlm.nih.gov/12723727"},"language":"en","primary_location":{"id":"doi:10.1111/j.1742-1241.2003.tb10467.x","doi":"https://doi.org/10.1111/j.1742-1241.2003.tb10467.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1742-1241.2003.tb10467.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1742-1241.2003.tb10467.x","source":{"id":"https://openalex.org/S22344484","display_name":"International Journal of Clinical Practice","issn_l":"1368-5031","issn":["1368-5031","1742-1241"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Clinical Practice","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1742-1241.2003.tb10467.x","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052127188","display_name":"J\u2010Bloom Corey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2803209242","display_name":"University of California System","ror":"https://ror.org/00pjdza24","country_code":"US","type":"education","lineage":["https://openalex.org/I2803209242"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"J\u2010Bloom Corey","raw_affiliation_strings":["Department of Neurosciences, University of California, La Jolla, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurosciences, University of California, La Jolla, California, USA","institution_ids":["https://openalex.org/I2803209242"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5052127188"],"corresponding_institution_ids":["https://openalex.org/I2803209242"],"apc_list":{"value":2350,"currency":"USD","value_usd":2350},"apc_paid":null,"fwci":3.8584,"has_fulltext":true,"cited_by_count":68,"citation_normalized_percentile":{"value":0.93231255,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"57","issue":"3","first_page":"219","last_page":"223"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.7939000129699707,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.7939000129699707,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.1500999927520752,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.02539999969303608,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/galantamine","display_name":"galantamine","score":1.0},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9919999837875366},{"id":"https://openalex.org/keywords/vascular-dementia","display_name":"vascular dementia","score":1.0},{"id":"https://openalex.org/keywords/acetylcholinesterase-inhibitors","display_name":"acetylcholinesterase inhibitors","score":0.906000018119812},{"id":"https://openalex.org/keywords/dual-mechanism-of-action","display_name":"dual mechanism of action","score":0.9139999747276306},{"id":"https://openalex.org/keywords/cognitive-function","display_name":"cognitive function","score":0.6349999904632568},{"id":"https://openalex.org/keywords/activities-of-daily-living","display_name":"activities of daily living","score":0.9509999752044678},{"id":"https://openalex.org/keywords/behavioural-symptoms","display_name":"behavioural symptoms","score":0.6859999895095825},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7329999804496765},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.8270000219345093},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.6520000100135803}],"concepts":[{"id":"https://openalex.org/C2779056891","wikidata":"https://www.wikidata.org/wiki/Q412690","display_name":"Galantamine","level":5,"score":0.9817200899124146},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.8067939281463623},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8007183074951172},{"id":"https://openalex.org/C2777952318","wikidata":"https://www.wikidata.org/wiki/Q583908","display_name":"Vascular dementia","level":4,"score":0.7488422393798828},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7181777954101562},{"id":"https://openalex.org/C2778816929","wikidata":"https://www.wikidata.org/wiki/Q22676679","display_name":"Acetylcholinesterase","level":3,"score":0.6963488459587097},{"id":"https://openalex.org/C2777544248","wikidata":"https://www.wikidata.org/wiki/Q2592323","display_name":"Acetylcholinesterase inhibitor","level":4,"score":0.6161990165710449},{"id":"https://openalex.org/C502032728","wikidata":"https://www.wikidata.org/wiki/Q11081","display_name":"Alzheimer's disease","level":3,"score":0.5256263613700867},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4371112287044525},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4152162969112396},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.36480408906936646},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.362000435590744},{"id":"https://openalex.org/C2780904820","wikidata":"https://www.wikidata.org/wiki/Q415081","display_name":"Donepezil","level":4,"score":0.1648063361644745},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.07247716188430786},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.057871997356414795},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002800","descriptor_name":"Cholinesterase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005702","descriptor_name":"Galantamine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015140","descriptor_name":"Dementia, Vascular","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1111/j.1742-1241.2003.tb10467.x","doi":"https://doi.org/10.1111/j.1742-1241.2003.tb10467.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1742-1241.2003.tb10467.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1742-1241.2003.tb10467.x","source":{"id":"https://openalex.org/S22344484","display_name":"International Journal of Clinical Practice","issn_l":"1368-5031","issn":["1368-5031","1742-1241"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Clinical Practice","raw_type":"journal-article"},{"id":"pmid:12723727","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12723727","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of clinical practice","raw_type":"Journal Article"},{"id":"mag:2300314858","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12723727","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":{"id":"doi:10.1111/j.1742-1241.2003.tb10467.x","doi":"https://doi.org/10.1111/j.1742-1241.2003.tb10467.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1742-1241.2003.tb10467.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1742-1241.2003.tb10467.x","source":{"id":"https://openalex.org/S22344484","display_name":"International Journal of Clinical Practice","issn_l":"1368-5031","issn":["1368-5031","1742-1241"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Clinical Practice","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4367363087.pdf","grobid_xml":"https://content.openalex.org/works/W4367363087.grobid-xml"},"referenced_works_count":54,"referenced_works":["https://openalex.org/W1584669232","https://openalex.org/W1867923226","https://openalex.org/W1939947624","https://openalex.org/W1941904320","https://openalex.org/W1953027527","https://openalex.org/W1955195137","https://openalex.org/W1966528911","https://openalex.org/W1978575746","https://openalex.org/W1994067502","https://openalex.org/W1996776294","https://openalex.org/W2000352547","https://openalex.org/W2005170015","https://openalex.org/W2006221546","https://openalex.org/W2027372983","https://openalex.org/W2036338786","https://openalex.org/W2039132949","https://openalex.org/W2041226345","https://openalex.org/W2041267132","https://openalex.org/W2041682618","https://openalex.org/W2043467860","https://openalex.org/W2045836468","https://openalex.org/W2046185822","https://openalex.org/W2047780020","https://openalex.org/W2050876413","https://openalex.org/W2051182801","https://openalex.org/W2053189460","https://openalex.org/W2059729306","https://openalex.org/W2067031806","https://openalex.org/W2070501794","https://openalex.org/W2079622868","https://openalex.org/W2084010840","https://openalex.org/W2084404544","https://openalex.org/W2091110888","https://openalex.org/W2091608383","https://openalex.org/W2093018325","https://openalex.org/W2102343148","https://openalex.org/W2107327698","https://openalex.org/W2111963393","https://openalex.org/W2112234680","https://openalex.org/W2116497718","https://openalex.org/W2117134611","https://openalex.org/W2119106204","https://openalex.org/W2122692162","https://openalex.org/W2129678592","https://openalex.org/W2129827820","https://openalex.org/W2137103253","https://openalex.org/W2152370183","https://openalex.org/W2262285055","https://openalex.org/W2397740639","https://openalex.org/W2402684904","https://openalex.org/W2949740636","https://openalex.org/W4256536916","https://openalex.org/W4281687410","https://openalex.org/W4300662929"],"related_works":["https://openalex.org/W2057271207","https://openalex.org/W2170783468","https://openalex.org/W2019924732","https://openalex.org/W3021747155","https://openalex.org/W2034135101","https://openalex.org/W2076496598","https://openalex.org/W2071970806","https://openalex.org/W2045836468","https://openalex.org/W2090865977","https://openalex.org/W2412493382"],"abstract_inverted_index":{"Dementia":[0],"has":[1],"the":[2,22,44,64],"potential":[3,141],"to":[4,15,103,119,127],"become":[5],"a":[6,50],"major":[7],"public":[8],"health":[9],"concern":[10],"during":[11],"this":[12],"century":[13],"due":[14],"increasing":[16],"life":[17],"expectancy":[18],"and":[19,37,57,66,75,92,108,121],"growth":[20],"in":[21,70,105,110],"ageing":[23],"population.":[24],"The":[25,112],"commonest":[26],"types":[27],"of":[28,53,55,68,89,114,132,136],"dementia":[29,35,38],"include":[30],"Alzheimer's":[31],"disease":[32],"(AD),":[33],"vascular":[34],"(VaD),":[36],"with":[39,72,77,97],"cerebrovascular":[40,78],"components.":[41,79],"Galantamine":[42,80],"is":[43],"only":[45],"acetylcholinesterase":[46,56],"inhibitor":[47],"that":[48],"exhibits":[49],"dual":[51],"mechanism":[52,135],"action--inhibition":[54],"nicotinic":[58],"receptor":[59],"modulation.":[60],"Clinical":[61],"studies":[62],"demonstrate":[63],"efficacy":[65],"safety":[67],"galantamine":[69,98,115,138],"patients":[71],"AD,":[73],"VaD,":[74],"AD":[76],"shows":[81],"beneficial":[82],"effects":[83],"on":[84],"cognition,":[85],"global":[86],"function,":[87],"activities":[88],"daily":[90],"living":[91],"behaviour.":[93],"Adverse":[94],"events":[95],"observed":[96],"use":[99],"are":[100],"generally":[101],"mild":[102],"moderate":[104],"severity,":[106],"transient":[107],"gastrointestinal":[109],"nature.":[111],"dose":[113],"should":[116],"be":[117],"escalated":[118],"16":[120],"24":[122],"mg/day":[123],"at":[124],"four-week":[125],"intervals":[126],"achieve":[128],"maximal":[129],"tolerability.":[130],"Because":[131],"its":[133],"unique":[134],"action,":[137],"may":[139],"have":[140],"benefits":[142],"over":[143],"conventional":[144],"enzyme-inhibiting":[145],"agents.":[146]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2023-04-30T00:00:00"}